Latest News and Press Releases

LOS ANGELES, May 02, 2025 (GLOBE NEWSWIRE) -- Kevin Vilkin, co-founder of Emergent Strategic Partners, has joined the Milken Young Leaders Circle (YLC), an honor awarded to outstanding executives,...

AUSTIN, Texas, April 25, 2025 (GLOBE NEWSWIRE) -- Kevin Vilkin, co-founder of Emergent Strategic Partners, has been accepted as a member of Business Executives for National Security (BENS), a...

AUSTIN, Texas, April 18, 2025 (GLOBE NEWSWIRE) -- Kevin Vilkin, co-founder of Emergent Strategic Partners, has been appointed to the Board of Directors of Conservation International, a leading...

GAITHERSBURG, Md., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it entered into a new credit agreement on September 30, 2024 providing for an...

SAN DIEGO, Sept. 20, 2023 (GLOBE NEWSWIRE) -- National law firm Morris Kandinov is investigating the actions of the officers and board of directors of Emergent BioSolutions Inc., James River Group...

GAITHERSBURG, Md., July 06, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that the company’s board of directors appointed Sujata Dayal as a Class II director to...

GAITHERSBURG, Md., June 24, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that the U.S. Food and Drug Administration (FDA) accepted for review the Biologics License...

GAITHERSBURG, Md., June 02, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s executive management team will participate in the following...

Expands and further diversifies Emergent’s medical countermeasures portfolio with the addition of a small molecule therapeutic addressing a high priority public health threatTransaction to be funded...

GAITHERSBURG, Md., May 12, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that its 2022 Annual Meeting of Stockholders will be held in a virtual-only format via live...